Introducing a Novel Chemotherapeutic Drug for the Treatment of Lung Adenocarcinoma: Silver Nanoparticles Green-formulated by Cinnamomum verum

J Oleo Sci. 2022 Mar 2;71(3):371-378. doi: 10.5650/jos.ess21316. Epub 2022 Feb 15.

Abstract

In this study we report the green synthesis of nontoxic, stable, and small size silver nanoparticle by Cinnamomum verum with reducing/capping ability without any toxic reducing agents. The in situ prepared AgNPs were characterized by advanced physicochemical techniques like FE-SEM, TEM, and UV-Vis study. It has been established that AgNPs have a spherical shape with a mean diameter from 10 to 45 nm. In the antioxidant test, the IC50 of AgNPs and BHT against DPPH free radicals were 191 and 242 µg/mL, respectively. In the cellular and molecular part of the recent study, the treated cells with AgNPs were assessed by MTT assay for 48 h about the cytotoxicity and anti-human lung adenocarcinoma properties on normal (HUVEC) and lung adenocarcinoma cell lines i.e. PC-14, LC-2/ad, and HLC-1. The IC50 of AgNPs were 259, 291, and 395 µg/mL against PC-14, LC-2/ad, and HLC-1 cell lines, respectively. The viability of malignant lung cell line reduced dose-dependently in the presence of AgNPs.

Keywords: Cinnamomum verum; antioxidant; lung cancer; silver nanoparticles.

MeSH terms

  • Adenocarcinoma of Lung* / drug therapy
  • Anti-Bacterial Agents
  • Cinnamomum zeylanicum
  • Humans
  • Metal Nanoparticles* / chemistry
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Silver / chemistry
  • Silver / pharmacology

Substances

  • Anti-Bacterial Agents
  • Plant Extracts
  • Silver